OCLN

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA005933

Antibody CAB013075

Antibody CAB068212

Antibody CAB068213

Antibody CAB068214

Tissue

Antibody staining

Antibody staining

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant cells generally showed weak to moderate positivity. Malignant lymphomas and gliomas were negative.Cholangiocarcinomas and endometrial cancers displayed strong cytoplasmic and cellmembranous staining in a majority of cases. Skin cancers, malignant gliomas, lymphomas and melanomas were negative.Several cancer types showed weak to moderate cytoplasmic or membranous positivity. Gliomas, lymphomas, melanomas, skin and renal cancers were negative.Most cancer tissues showed weak to moderate membranous and cytoplasmic positivity. Few cases of pancreas, prostate, colorectal and testis cancers displayed strong membranous and/or cytoplasmic immunoreactivity. Lymphomas, gliomas, melanomas, skin cancers and most renal cell carcinomas were negative.Majority of cancer tissues showed weak to moderate membranous and/or cytoplasmic positivity. Lymphomas, gliomas, melanomas, carcionids, renal cell carcinomas and skin cancers were in general negative.

Literature conformity

Consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected